Elevated C-reactive protein is associated with shortened leukemia-free survival in patients with myelofibrosis

Leukemia. 2013 Oct;27(10):2084-6. doi: 10.1038/leu.2013.207. Epub 2013 Jul 5.

Authors

T Barbui¹, A Carobbio, G Finazzi, P Guglielmelli, S Salmoiraghi, V Rosti, A Rambaldi, A M Vannucchi, G Barosi

Affiliation

¹ 1] Fondazione per la Ricerca Ospedale Maggiore (FROM), Ospedale Papa Giovanni XXIII, Bergamo, Italy [2] Divisione di Ematologia, Ospedale Papa Giovanni XXIII, Bergamo, Italy.

PMID: 23828261
DOI: 10.1038/leu.2013.207

No abstract available

Publication types

Comparative Study
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Aged
Aged, 80 and over
Biomarkers, Tumor / blood*
C-Reactive Protein / metabolism*
Case-Control Studies
Female
Follow-Up Studies
Humans
Leukemia / etiology
Leukemia / mortality
Leukemia / pathology*
Male
Middle Aged
Primary Myelofibrosis / blood
Primary Myelofibrosis / complications
Primary Myelofibrosis / mortality*
Prognosis
Prospective Studies
Survival Rate

Substances

Biomarkers, Tumor
C-Reactive Protein